Teerikorpi will deliver a presentation titled, "Autopilot With Guardrails: Designing AI-Assisted Database Operations Without ...
Google is telling its database engineers to lean on AI coding tools as heavily as they want while contributing to open source ...
MongoDB hits its first GAAP operating profit as Atlas drives growth and free cash flow surges. Read why I remain bullish ...
Morning Overview on MSN
PerturbFate, a new AI, can now forecast how tens of thousands of mutations push cells toward cancer at once — pointing drug makers straight at the ones that matter
Melanoma kills roughly 8,000 Americans each year, and a stubborn share of those deaths trace back to the same problem: tumors ...
Synology today announced the general availability of PAS7700, the company's first active-active, all flash NVMe storage system. Built for mission-critical workloads, PAS7700 delivers enterprise-grade ...
Vietnam Investment Review on MSN
Synology launches PAS7700 its first all flash NVMe active active storage system
SINGAPORE - Media OutReach Newswire - 21 May 2026 – Synology today announced the general availability of PAS7700, the company's first active-active, all flash NVMe storage system. Built for ...
Confluent, an IBM Company and the data streaming pioneer, today announced new capabilities in Confluent Intelligence and Confluent Cloud that streamline how real-time artificial intelligence (AI) ...
Container shipping on the high seas, and the broader maritime industry, are set to benefit from transformative real-time agentic AI-based connectivity and monitoring capabilities, thanks to a new ...
A new study provides the first empirical proof of an AI passing the Turing test, with GPT-4.5 reaching a 73% human score.
The Bundibugyo ebolavirus (BDBV) poses a significant threat with a fatality rate as high as 40%. Current efforts are focused on developing effective vaccines and treatments to combat this deadly ...
Morning Overview on MSN
A new tool called PerturbFate can now predict how thousands of genetic mutations drive disease at once — aimed squarely at cancer and Alzheimer’s
A melanoma cell can dodge a targeted drug in dozens of different ways, each driven by a different genetic mutation. But what ...
Strong inhibition at less than half the concentration of the clinically-tested COVID-19 (0.28μM).Clinical safety confirmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results